Board of Directors

Anders Ekblom
Chairman of the Board
    • Board member since: 2017
    • Independent in relation to the Company and its management: Yes
    • Independent in relation to major shareholders: Yes
    • Holdings in Alligator: 302,809 shares, 100,000 warrants in program TO 2022/2025 II, and 240,000 warrants in program TO 2023/2026 II.
    • Other current positions: Chairman of Atrogi AB, Elypta AB and Xspray Pharma AB. Board member of AnaMar AB, Flerie Invest AB and Mereo BioPharma Group plc
    Hans-Peter Ostler
    Vice chairman of the Board
      • Board member since: 2021
      • Independent in relation to the Company and its management: Yes
      • Independent in relation to major shareholders: Yes
      • Holdings in Alligator: 3,411,884 shares, 100,000 warrants in program TO 2022/2025 II, and 240,000 warrants in program TO 2023/2026 II.
      • Other current positions: Chairman of the Board in Ectin Research AB and Improve Tec Hönö AB, board member of, Hoodin AB, InorbitTX, Oblique Therapeutics AB and Lennart Ekerholms Stiftelse. Deputy board member in O Mgmt AB.
      Staffan Encrantz
      Board member
        • Board member since: 2022
        • Independent in relation to the Company and its management: Yes
        • Independent in relation to major shareholders: No
        • Holdings in Alligator: 205,840,049 shares.
        • Other current positions: Chairman of AnaMar AB, Sweden, a company engaged in the research and development of drugs for fibrosis, Koncentra AB, Sweden, a contract manufacturing group, Nclear Inc., Atlanta GA, a company in the water treatment business, Oxymetal SAS, France a laser and plasma steel cutting business and Sight Sciences Inc., Menlo Park CA, an eye care company developing and selling devices for surgical treatment of glaucoma and dry eye. Board member of KS Large Bore Pistons GmBH.
        Denise Goode
        Board member
          • Board member since: 2022
          • Independent in relation to the Company and its management: Yes
          • Independent in relation to major shareholders: Yes
          • Holdings in Alligator: 240,000 warrants in program TO 2023/2026 II
          • Other current positions: CEO of QED Life Sciences Limited, a consultancy company advising and supporting the strategic direction of biotech companies and providing business mentoring to CEOs and senior leaders. Board member of Abliva AB (publ) where she is chair of the remuneration committee and a member of the audit committee. VP, Business Development at AnaMar AB. Certified COVID vaccinator for the UK National Health Service.
          Eva Sjökvist Saers
          Board member
            • Board member since: 2021
            • Independent in relation to the Company and its management: Yes
            • Independent in relation to major shareholders: Yes
            • Holdings in Alligator: 100,000 warrants in program TO 2022/2025 II and 240,000 warrants in program TO 2023/2026 II.
            • Other current positions: Chairman of the board of Dicot AB (publ) and Coegin Pharma AB. Board member of Apoex AB, Bluefish Pharmaceuticals AB (publ) and Oxcia AB. Deputy board member of Brainstorm Aktiebolag.
            Karin Nordbladh
            Employee representative
              • Board member since: 2023
              • Independent in relation to the Company and its management: No
              • Independent in relation to major shareholders: Yes
              • Holdings in Alligator: 22,750 shares.

              Updated 2024-05-08